Ownership history in TCM Advisors, LLC Β· 16 quarters on record
This page tracks every 13F SEC filing in which TCM Advisors, LLC reported a position in MEDTRONIC PLC (MDT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π TCM Advisors, LLC underperformed the S&P 500 by β9.5% annually on this MDT position. Timing score: 36% (5/14 decisions correct). Average cost basis: $90.11. Maximum drawdown during holding period: β28.2%.
β Significantly underperformed the S&P 500 by 9.5% ann.
11 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
5 of 14 add/trim decisions correct
Best entry: $72.58 (2022 Q3) Β· Worst: $98.17 (2022 Q1)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
8 adds Β· 7 trims. Bought during 3 of 7 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.08% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size